Cardiology – Medxy AI

Cardiovascular and Bone Health Outcomes After Oophorectomy in Postmenopausal Women Undergoing Benign Hysterectomy: Insights from a Population-Based Study

By MedXY 09/08/2026

This study evaluates cardiovascular and bone health outcomes after bilateral oophorectomy during benign hysterectomy in postmenopausal women, highlighting increased risk for cardiovascular predisposition but no rise in clinical cardiovascular events or osteoporosis.

Cardiology Hematology-Oncology news

Impact of Germline and Somatic DNMT3A Variants on Pulmonary Arterial Hypertension: A New Frontier in Biomarkers and Therapeutics

By MedXY 09/08/2026

Germline and somatic variants in DNMT3A and other CHIP genes elevate pulmonary arterial hypertension risk, including connective tissue disease-associated forms, through pro-inflammatory pathways, highlighting novel biomarkers and therapeutic targets.

Cardiology news Radiology

Enhancing Diagnostic Accuracy in Stable Coronary Artery Disease: Impact of Adding CT-derived Fractional Flow Reserve (FFRct) – Insights from the FUSION Trial

By MedXY 09/08/2026

The FUSION randomized trial demonstrates that adding CT-derived FFR to coronary CTA significantly reduces unnecessary invasive angiographies without affecting clinical outcomes, cost, or quality of life in stable CAD patients with intermediate stenosis.

Cardiology news

Evaluating Vericiguat in Coronary Vasospasm: Insights from the ViVA Randomized Cross-Over Trial

By MedXY 09/08/2026

This article reviews the ViVA trial assessing vericiguat, an sGC stimulator, in angina patients with coronary vasospasm but no obstructive coronary artery disease. The study found no significant improvement in vasodilator function or angina symptoms, though vericiguat was well tolerated.

Cardiology news Rheumatology

Tocilizumab Reduces Major Cardiovascular Events Risk in Giant Cell Arteritis: Insights from a Nationwide French Cohort

By MedXY 09/08/2026

A nationwide observational study reveals tocilizumab use in giant cell arteritis significantly lowers major adverse cardiovascular events compared to methotrexate, highlighting its potential cardiovascular benefits beyond inflammation control.

Cardiology news

Evolocumab Significantly Reduces Mortality in High-Risk Patients Without Prior Heart Attack or Stroke: Insights from the VESALIUS-CV Trial

By MedXY 09/08/2026

The VESALIUS-CV trial demonstrates that evolocumab lowers all-cause and cardiovascular mortality in patients with high cardiovascular risk but no prior myocardial infarction or stroke, highlighting its survival benefits in primary prevention.

Cardiology news

Protocol-Based Early Intensive Lipid Management Significantly Enhances LDL-C Target Achievement Post-Acute Coronary Syndrome: Insights from the BRIDGE Trial

By MedXY 09/07/2026

The BRIDGE trial demonstrates that protocol-driven early intensive lipid-lowering therapy significantly improves guideline-recommended LDL-C target attainment in acute coronary syndrome patients, fostering better cardiovascular risk control.

Cardiology Neurology news

Ticagrelor-Aspirin Dual Therapy After Thrombolysis in Moderate Ischemic Stroke: Insights from Infarct Patterns in the TAPIS Trial

By MedXY 09/06/2026

TAPIS subgroup analysis reveals that ticagrelor-aspirin combined with thrombolysis may improve outcomes in moderate ischemic stroke patients with multiple acute infarcts, without increasing hemorrhage risk, suggesting infarct pattern as a potential guide for early antiplatelet therapy.

Cardiology Neurology news

Unraveling Central Autonomic Network Disruptions Underlying Cardiorespiratory Dysfunction in Temporal Lobe Epilepsy

By MedXY 09/06/2026

This study reveals that central autonomic network alterations in temporal lobe epilepsy patients contribute to interictal cardiorespiratory dysfunction, potentially increasing SUDEP risk, and highlights connectivity changes post-surgery impacting autonomic function.

Cardiology news

Obesity-Driven Left Atrial Remodeling in Atrial Fibrillation: Insights from Invasive Pressure-Volume Analysis

By MedXY 09/06/2026

This study reveals distinct left atrial structural and functional changes associated with obesity in atrial fibrillation patients, highlighting a load-related atrial remodeling that may underlie increased risks of atrial fibrillation and heart failure with preserved ejection fraction.

Cardiology news Respiratory

Integrating Left Ventricular and Right Atrial Strain for Enhanced Prognostic Prediction in Pulmonary Arterial Hypertension

By MedXY 09/06/2026

Combining left ventricular global longitudinal strain and right atrial reservoir strain greatly improves risk prediction and stratification in pulmonary arterial hypertension, outperforming conventional imaging and clinical models.

Cardiology news

Long-Term Comparative Outcomes of Bilateral versus Single Internal Thoracic Artery Grafts in Coronary Bypass Surgery

By MedXY 09/06/2026

This analysis of a randomized trial finds no survival benefit at 15 years for bilateral versus single internal thoracic artery grafting in coronary bypass surgery, highlighting the need for further trials to clarify the multiple arterial graft hypothesis.

Cardiology news

Harnessing Genetic Insights: Polygenic Risk Score Enhances Prediction of Peripheral Artery Disease and Limb Events

By MedXY 09/06/2026

A validated polygenic risk score (PRS) independently predicts peripheral artery disease (PAD) and major adverse limb events (MALE) in patients with cardiometabolic disease, adding modest but significant predictive value beyond traditional clinical risk factors.

Cardiology news

Validated Risk Stratification for RYR2-Mediated Catecholaminergic Polymorphic Ventricular Tachycardia on Beta-Blocker Therapy

By MedXY 09/06/2026

This article reviews a validated clinical risk model predicting arrhythmic events in patients with RYR2-mediated CPVT receiving beta-blockers, facilitating personalized management to reduce life-threatening arrhythmias.

Cardiology news

Stent Retriever Thrombectomy Reduces Infarct Size in High-Thrombus Myocardial Infarction: Insights from the NATURE Trial

By MedXY 09/06/2026

The NATURE trial demonstrates that stent retriever thrombectomy combined with conventional PCI significantly reduces infarct size in STEMI patients with large thrombus burden, without increasing short-term adverse events.

Cardiology news

Lepodisiran’s Impact on Oxidized Phospholipids in Lipoprotein(a): Advancing Cardiovascular Risk Reduction

By MedXY 09/06/2026

Lepodisiran, an siRNA targeting Lp(a), significantly reduces oxidized phospholipids on apo(a) and apoB, highlighting its therapeutic potential in lowering cardiovascular risk linked to elevated Lp(a).

Cardiology news

Advancing Familial Hypercholesterolemia Diagnosis: Activity-Normalized Prime Editing for Comprehensive LDLR Variant Classification

By MedXY 09/06/2026

A novel prime editing screening method enables precise functional classification of LDLR gene variants, enhancing diagnosis and therapeutic strategies for familial hypercholesterolemia.

Cardiology news

Targeting the CXCL9/CXCL10-CXCR3+ CD8+ T Cell Axis: Unraveling Anti-PD-1 Antibody-Associated Cardiotoxicity in Pressure Overload Heart Failure

By MedXY 09/06/2026

Anti-PD-1 antibody exacerbates pressure overload-induced heart failure by promoting CXCR3+ CD8+ T cell infiltration, which impairs cardiomyocyte mitochondrial function via granzyme B and perforin. This study identifies a novel immunopathogenic mechanism and therapeutic targets to mitigate cardiotoxicity.

Cardiology news

Enhancing Heart Failure Care: Impact of Get With The Guidelines-Heart Failure Hospital Participation on Medical Therapy and Patient Outcomes

By MedXY 09/04/2026

Participation in the GWTG-HF program modestly improves guideline-directed medical therapy intensity and reduces short- and long-term mortality in patients hospitalized for heart failure with reduced ejection fraction.

Cardiology news Pediatrics

Genetic Insights into Childhood Blood Pressure and Heart Rate: Implications for Adult Cardiometabolic Health

By MedXY 09/04/2026

Large-scale GWAS highlight novel genetic loci influencing childhood blood pressure and heart rate, with polygenic risk scores predicting adult cardiometabolic outcomes, underscoring the importance of early-life genetic determinants in cardiovascular risk stratification and prevention.